Dishman Carbogen Amcis Limited (DCAL) Share Price & AI Investment Analysis

Dishman Carbogen Amcis Limited provides contract development and manufacturing organization (CDMO) services for the pharmaceutical and healthcare industries worldwide. It operates through Integrated CDMO Platform and Marketable Molecules segments. The company offers cholesterol and vitamin D analogs; soft gel capsules and formulations; intermediate and active pharmaceutical ingredients (APIs) which cover specific therapeutic areas, such as anesthetics, and contrast media agents for diagnostics, ophthalmic treatments, laxatives, and organophosphate antidotes; ammonium and phosphonium; quats, ph. Track Dishman Carbogen Amcis Limited's live NSE:DCAL share price ₹168.19 (-2.97%), market cap ₹₹26B, P/E 27.0. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for DCAL — real-time NSE India stock intelligence.